Ratner Biomedical Group is categorized under Research and Development Laboratories in Redmond, WA and active since 2006.
Ratner Biomedical Group was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Stephen Quinn at the company’s single location by writing to 5803 231st Avenue Ne, Redmond, Washington WA 98053 or by phoning (425) 269-3478. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ratner Biomedical Group |
| Contact Person: | Stephen Quinn |
| Address: | 5803 231st Avenue Ne, Redmond, Washington 98053 |
| Phone Number: | (425) 269-3478 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Ratner Biomedical Group was started in 2006 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stephen Quinn for inquiries that concern Ratner Biomedical Group by calling the company number (425) 269-3478, as your correspondence is most welcome. Additionally, the physical location of the single location of Ratner Biomedical Group can be found at the coordinates 47.659828,-122.03081 as well as the street address 5803 231st Avenue Ne in Redmond, Washington 98053.
For its online presence, you may visit Ratner Biomedical Group’s website at and engage with its social media outlets through on Twitter and on Facebook.